OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
OpenAI researcher Miles Wang is leaving to start an AI drug discovery company. He's in talks to raise around $200M at a $2B valuation, with Lightspeed discussing a lead role. Several other OpenAI researchers are expected to join. Wang disputed the funding figures and company description, though the post doesn't specify which parts. Talks are ongoing and details could change.
Why it matters: OpenAI researcher Miles Wang plans to leave and found an AI drug discovery company, in talks for about $200M at a $2B valuation, though he disputes parts of the report.